menu
    • menu

    Company profile for J Ints Bio

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    J INTS BIO is a bioscience company specializing in the development of anticancer drugs and orphan drugs. We then seek to maximize the value of these products by bringing them through the development and regulatory process in an expedited and cost-effective manner. In this way, we increase the product value and open the way for early market access, out-licensing or acquisition, both globally and regionally. At J INT...
    J INTS BIO is a bioscience company specializing in the development of anticancer drugs and orphan drugs. We then seek to maximize the value of these products by bringing them through the development and regulatory process in an expedited and cost-effective manner. In this way, we increase the product value and open the way for early market access, out-licensing or acquisition, both globally and regionally. At J INTS BIO, we are the chrysalis and a positive force in bringing life changing and health improving products to patients worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    J Ints Biokorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    49, Achasan-ro 17-gil, Seongdong-gu, Seoul
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://jintsbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    J Ints Bio to Present Global Clinical Results at ASCO 2025
    J Ints Bio to Present Global Clinical Results at ASCO 2025

    01 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/j-ints-bio-to-present-global-clinical-results-from-jin-a02-a-fourth-generation-egfr-tki-at-asco-2025-302470257.html

    PR NEWSWIRE
    01 Jun 2025
    Share Share
    J INTS BIO Presents Research Results for Anticancer Therapeutics
    J INTS BIO Presents Research Results for Anticancer Therapeutics

    30 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/j-ints-bio-presents-research-results-for-next-generation-innovative-anticancer-therapeutics-jin-a02-and-jin-001-at-aacr-2025-302442188.html

    PR NEWSWIRE
    30 Apr 2025
    Share Share
    J INTS BIO Launches AI-Supercomputing Alliance for Cancer Therapy
    J INTS BIO Launches AI-Supercomputing Alliance for Cancer Therapy

    05 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/j-ints-bio-launches-ai-supercomputing-alliance-to-transform-cancer-therapy-302296431.html

    PR NEWSWIRE
    05 Nov 2024
    Share Share
    J Ints Bio Presents Interim Findings From Phase 1/2 Trial Of JIN-A02
    J Ints Bio Presents Interim Findings From Phase 1/2 Trial Of JIN-A02

    24 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/j-ints-bio-presents-interim-findings-from-phase-12-clinical-trial-of-4th-generation-egfr-tki-jin-a02-in-nsclc-a-potential-breakthrough-in-overcoming-acquired-resistance-to-targeted-therapy-302285444.html

    PR NEWSWIRE
    24 Oct 2024
    Share Share
    J INTS BIO's JIN-A02 Shows Tumor, Brain Metastasis Reductions In Phase 1
    J INTS BIO's JIN-A02 Shows Tumor, Brain Metastasis Reductions In Phase 1

    10 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/j-ints-bio-asco-2024--jin-a02-showed-tumor-reductions-including-brain-metastasis-in-the-ongoing-first-in-human-dose-finding-phase-1-clinical-study-302168022.html

    PR NEWSWIRE
    10 Jun 2024
    Share Share
    JINS BIO: Novel EGFR TKI JIN-A02 Shows Phase 1 Benefits
    JINS BIO: Novel EGFR TKI JIN-A02 Shows Phase 1 Benefits

    11 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/j-ints-bio-aacr-2024--jin-a02-a-novel-oral-4th-generation-egfr-tki-showing-clinical-benefits-in-the-ongoing-phase-1-study-302114115.html

    PR NEWSWIRE
    11 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search